Skip to main content
. 2024 Dec 18;14(4):97219. doi: 10.5500/wjt.v14.i4.97219

Table 1.

Studies assessing plasma donor-derived cell-free DNA for the diagnosis of rejection using commercially available assays

Ref.
Assay used
Patient number
Threshold (%)
Sen/Spec
PPV/NPV
Bloom et al[3] AlloSure 102 1 59/85 61/84
Sigdel et al[5] Prospera 193 1 88.7/72.6 52/95
Huang et al[17] AlloSure 63 0.74 79/72 77/75
Bu et al[7] AlloSure 1092 0.5 78/71 50/90
Bromberg et al[8] Prospera 424 1 79/85.3 32.6/97.9

Sen: Sensitivity; Spec: Specificity; PPV: Positive predictive value; NPV: Negative predictive value.